Andere talen Calidi Biotherapeutics, Inc.

Aandelen

CLDI

US3207031010

Beurs gesloten - Nyse Andere beurzen 22:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,2 ^USD	-3,29%		+10,50%	-86,75%

27/06	Calidi Biotherapeutics, Inc. Benoemt George E. Peoples tot lid van de Raad van Bestuur	CI
10/06	Sectorupdate: Gezondheidszorgaandelen stijgen laat in de middag	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors	27/06
Calidi Biotherapeutics, Inc. Appoints George E. Peoples to Its Board of Directors	27/06
Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13	11/06
Sector Update: Health Care Stocks Advance Late Afternoon	10/06
Sector Update: Health Care	10/06
Calidi Biotherapeutics Signs Virotherapy Deal With Siga Technologies -- Calidi Shares Surge Pre-Bell	10/06
Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors	10/06
Calidi Biotherapeutics Collaborates with Siga Technologies to Advance Calidi?S Revolutionary Rtnova Virotherapy for Lung Cancer and Metastatic Solid Tumors	10/06
Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting	03/06
Calidi Biotherapeutics Presents Cld-101 Phase 1 Trial Update and Preclinical Data Highlighting Rtnova and Cld-201 At 2024 Asco Annual Meeting	03/06
Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds	31/05
Calidi Biotherapeutics, Inc. Announces Resignation of David Lapre as Director	16/05
Calidi Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results	14/05
Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting	01/05
Join Calidi Biotherapeutics Exclusive Live Investor Webinar and Q&A Session on April 24	24/04
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24	23/04
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering	19/04
Calidi Biotherapeutics Prices $6.1 Million Offering	16/04
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering	16/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Calidi Biotherapeutics, Inc.

Aandelen

CLDI

US3207031010

Andere talen

Filters